Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Baxter’s Gammagard Liquid Drug Gets New Approval

By Pharmaceutical Processing | June 26, 2012

DEERFIELD, Ill. (AP) — Baxter International Inc. said Monday that it received an additional market approval for its drug Gammagard Liquid for weakened immune systems; it can now be used in the U.S. to treat a rare autoimmune disorder.

The Food and Drug Administration approved Gammagard Liquid as a treatment for multifocal motor neuropathy, which is marked by progressive weakness in the limbs. Baxter said the disorder affects one or two out of every 100,000 people in the U.S.

Gammagard Liquid is the first immunoglobulin treatment approved for the condition.

The drug was first approved in the U.S. in 2005 as a treatment for weakened immune systems. It was approved in Europe in 2006 under the name Kiovig. European Union regulators approved Kiovig as a treatment for multifocal motor neuropathy in June 2011.

Shares of Baxter International lost 37 cents to $51.50 in afternoon trading as the overall markets slipped.

 

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE